28 Results for "

hemostasis

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "hemostasis" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-D0199
CAS No.: 16178-48-6
Synonyms: Adenosine diphosphate disodium; ADP disodium
Adenosine 5'-diphosphate disodium is a nucleoside diphosphate. Adenosine 5'-diphosphate disodium is the product of ATP dephosphorylation by ATPases. Adenosine 5'-diphosphate disodium is a platelet aggregation agent for hemostasis and the development and extension of arterial thrombosis .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-137431
CAS No.: 2064121-65-7
Purity:  99.80%
Synonyms: BAY-2433334
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potently, and reversibly to the active site of FXIa and thereby inhibits its activity. Asundexian inhibits human FXIa in buffer with an IC50 of 1 nM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0149
CAS No.: 1197-18-8
Synonyms: cyclocapron
Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis. Tranexamic acid is a PROTAC linker. Tranexamic acid is used to synthesize PROTACs (e.g. LZ-07 (HY-172590)) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15827
CAS No.: 7497-07-6
Purity:  99.63%
Target:  

MMP

Research Areas:  

Cardiovascular Disease Cancer

NSC 405020 is a specific MMP14 inhibitor. NSC 405020 can directly interact with the hemopexin domain of MMP14. NSC 405020 reduces the expression of full length and active cleaved Notch3 (NICD3). NSC 405020 can be used to research vestibular schwannoma, hemostasis and thrombosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-125856
CAS No.: 1802425-99-5
Purity:  99.93%
Synonyms: BMS-986177; JNJ-70033093
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Milvexian is an orally bioavailable, small-molecule, reversible, direct antagonists of factor Xia, with the Ki of 0.11, 0.38, 0.64, 490, 350 nM for human, rabbit, dog, rat, mouse, respectively. Milvexian shows anti-thrombosis activity in vitro and in vivo, and can be used for thrombus study .
loading...
    loading...
Cat. No.: HY-Y1365
CAS No.: 9000-70-8
Gelatins is a non-toxic, non carcinogenic, biodegradable, and non irritating natural polymer derived from partial hydrolysis of collagen. Due to its strong liquid absorption and swelling ability, Gelatins has excellent hemostatic properties and can be used as a matrix material for the reduction, growth, and stability of metal nanoparticles. Gelatins can also be used for tumor cell culture and tumor therapy .
loading...
    loading...
Cat. No.: HY-132587
CAS No.: 1499251-18-1
Purity:  94.68%
Synonyms: ALN-AT3SC; SAR439774
Fitusiran (ALN-AT3SC) is a siRNA strategy. Fitusiran delivers siRNA targeting the SERPINC1 gene in hepatocytes to inhibit antithrombin synthesis. Fitusiran enhances thrombin activity and increases Thrombin generation, thereby restoring hemostatic function. Fitusiran can be used in hemophilia-related research .
loading...
    loading...
Cat. No.: HY-P9940
CAS No.: 1610943-06-0
Synonyms: ACE-910; RG6013

Target:  

Factor VIII

Research Areas:  

Cardiovascular Disease

Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
loading...
    loading...
Cat. No.: HY-B1074
CAS No.: 2624-44-4
Synonyms: Etamsylate
Ethamsylate (Etamsylate) is an orally active anti-hemorrhagic compound. Ethamsylate inhibits biosynthesis and action of prostaglandins. Ethamsylate has the potential to maintain early hemostasis as well as restores capillary resistance. Ethamsylate acts as an antiangiogenic factor, inhibiting wound healing and matrigel tubulogenesis. .
loading...
    loading...
Cat. No.: HY-N1393
CAS No.: 579-75-9
Synonyms: NSC 3778; O-Methylsalicylic acid; Salicylic acid methyl ether
2-Methoxybenzoic acid (NSC 3778; O-Methylsalicylic acid; Salicylic acid methyl ether) is a natural compound with potential salicylate-like effect. 2-Methoxybenzoic acid inhibits carbonic anhydrase activity, elevates intraplatelet cyclic guanosine monophosphate level, and suppresses cytosolic phospholipase A2 phosphorylation. 2-Methoxybenzoic acid suppresses platelet reactivity, including decreased spreading, retraction, and aggregation in platelets. 2-Methoxybenzoic acid ameliorates arterial thrombosis in a dose-dependent manner without affecting normal hemostasis in mice. 2-Methoxybenzoic acid can be used for the research of arterial thrombosis .
loading...
    loading...
Cat. No.: HY-132587A
Purity:  94.68%
Synonyms: ALN-AT3SC sodium; SAR439774 sodium
Fitusiran (ALN-AT3SC) sodium is a siRNA strategy. Fitusiran delivers siRNA targeting the SERPINC1 gene in hepatocytes to inhibit antithrombin synthesis. Fitusiran sodium enhances thrombin activity and increases Thrombin generation, thereby restoring hemostatic function. Fitusiran sodium can be used in hemophilia-related research .
loading...
    loading...
Cat. No.: HY-N2138
CAS No.: 152580-79-5
Buddlejasaponin IVb (Compound 2), a triterpene saponin isolated from Clinopodium chinense (Benth.) O. Kuntze, Compound 2 has hemostasis efficacy, shortens thrombin time (TT) by 20.6 % .
loading...
    loading...
Cat. No.: HY-131722
CAS No.: 389614-94-2
Purity:  98.75%
Target:  

Phospholipase

Research Areas:  

Cardiovascular Disease

EA4, a derivative of quinone, is an inhibitor for both rPLA and cPLA. EA4 can inhibit rPLA2 with a Ki value of 130 μM. EA4 can be used for the research of hemostasis, thrombosis, and erythropoiesis .
loading...
    loading...
Cat. No.: HY-D0199R
CAS No.: 16178-48-6
Synonyms: Adenosine diphosphate disodium (Standard); ADP disodium (Standard)
Adenosine 5'-diphosphate (disodium) (Standard) is the analytical standard of Adenosine 5'-diphosphate (disodium). This product is intended for research and analytical applications. Adenosine 5'-diphosphate disodium is a nucleoside diphosphate. Adenosine 5'-diphosphate disodium is the product of ATP dephosphorylation by ATPases. Adenosine 5'-diphosphate disodium is a platelet aggregation agent for hemostasis and the development and extension of arterial thrombosis .
loading...
    loading...
Cat. No.: HY-108739
CAS No.: 1362509-93-0
Synonyms: BI 655075

Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis .
loading...
    loading...
Cat. No.: HY-B0149R
CAS No.: 1197-18-8
Synonyms: cyclocapron (Standard)
Tranexamic acid (Standard) is the analytical standard of Tranexamic acid. This product is intended for research and analytical applications. Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis .
loading...
    loading...
Cat. No.: HY-10563
CAS No.: 125926-17-2
Synonyms: MCI-9042 free acid
Target:  

5-HT Receptor

Research Areas:  

Infection

Sarpogrelate (MCI-9042) is a new, specific orally active 5-HT2 receptor antagonist, Sarpogrelate increases platelet aggregation and has hemostasis effect, and can be used for the research of Buerger’s disease .
loading...
    loading...
Cat. No.: HY-B0149S2
Synonyms: Cyclocapron-13C6
Tranexamic acid- 13C6 (Cyclocapron- 13C6) is 13C labeled Tranexamic acid. Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis .
loading...
    loading...
Cat. No.: HY-125856A
CAS No.: 1802426-00-1
Synonyms: BMS-986177 TFA; JNJ-70033093 TFA
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Milvexian TFA (BMS-986177 TFA) is a factor XIa inhibitor with biological activity to prevent venous thromboembolism. Milvexian TFA was effective in reducing the occurrence of venous thromboembolism in patients undergoing knee replacement surgery. Milvexian TFA has good selectivity and shows significant inhibitory effects on plasma kallikrein and trypsin. Milvexian TFA has a bioavailability of 32%, which means it has a high absorption rate in the body. Milvexian TFA showed a relatively low risk of bleeding in clinical trials .
loading...
    loading...
Cat. No.: HY-162363
Target:  

PARP

Research Areas:  

Neurological Disease

MD6a is a melatonin derivative with inhibitroy activity towards PARP-1, which maintains proteins hemostasis and improves mitochondrial function through TOR/HSF-1 signaling. MD6a a neuroprotective effect .
loading...
    loading...